Translational research

Translational research projects encourage collaborations between basic and clinical research. Their goal is to study cells and their interactions with the environment, and in so doing to provide new impulses for novel therapies and clinical approaches in order to be able to act on the causes of cellular malfunction.  

Financial support for translational cancer research projects is possible thanks to:

"Allocated funds" - These funds are specifically created for each project. They come from private donations and must be used for the predetermined purpose. The Foundation guarantees that donations are used in full to finance the project to which they have been allocated.

“ISREC chairs” - These are created to offer young professors affiliated to the EPFL (School of Life Sciences - ISREC) or to a Swiss University (Faculty of biology or medicine) the opportunity to launch their career in research. They are financed by the fortune of the Foundation.

Translational research - ongoing projects

Advanced in vitro models of prostate cancer metastases: unravelling and overcoming ARSI resistance

This “allocated fund” was granted to Prof. Mark Rubin (University of Bern) in February 2022 for 2 years.

More information

Exploring the role of neutrophils in brain metastasis

This “allocated fund” was granted to Prof. Johanna Joyce (University of Lausanne, Oncology Department) in January 2021 for 3 years.

More information

Immune-modulatory radiotherapy to enhance the effects of neo-adjuvant PD-L1 blockade after neo-adjuvant chemotherapy in patients with resectable stage III (N2) non-small cell lung cancer (NSCLC)

This “allocated fund in clinical research” was granted in December 2020 to Dr. Sacha Rothschild (University Hospital Basel) for 3 years.

More information

Page 3 of 5.

News & Events

Posted on
A new study from Dr. Grégory Verdeil’s laboratory

Congratulations to Dr. Grégory Verdeil and his team on the publication of an article in the prestigious journal Nature Immunology, in which they were…

Read more
Posted on
SUR-SRP 2023: Congratulations to the six students supported by the ISREC Foundation!

Once again, the SUR-SRP “Summer Research” program (July 3 to August 25), organized by the UNIL and the EPFL and supported by the ISREC Foundation, was…

Read more
Posted on
Congratulations to the six research groups chosen for the TANDEM 2023 collaborative funding program

This year, six research groups working in Lausanne, Geneva, Bern and Bellinzona were awarded a TANDEM grant.

Each team, consisting of a clinician and…

Read more
Posted on
A gene pair may predict cancer progression

Congratulations to Prof. Mikaël Pittet, holder of the ISREC Foundation’s Immuno-Oncology Chair at the University of Geneva: in an article published in…

Read more
See all the news
© 2015 Fondation ISREC   |   Droits réservés